https://de.marketscreener.com/kurs/aktie/ETON-PHARMACEUTICALS-INC-47061927/news/Eton-Pharmaceuticals-erhalt-US-Patent-fur-firmeneigene-Hydrocortison-Flussigformulierung-zum-Einn-46014808/?utm_source=telegram&utm_medium=social&utm_campaign=share